John Hyngstrom

机构：Rush University Medical Center, The University of Texas MD Anderson Cancer Center, University of Utah, Huntsman Cancer Institute, Rush University · ORCID：0000-0002-4833-3838

发表论文 133 篇 · 总被引 3446 次 · h-index 25

代表论文

• Gene Expression Profile–Based Test to Predict Melanoma Sentinel Node Status (2025 · JAMA Surgery · 被引 12)
• Tattooing and risk of melanoma: a population-based case-control study in Utah (2025 · JNCI Journal of the National Cancer Institute · 被引 8)
• Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma (2026 · Clinical Cancer Research · 被引 7)
• Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial (2025 · Nature Medicine · 被引 7)
• 1601O 3-year survival with neoadjuvant-adjuvant pembrolizumab from SWOG S1801 (2025 · Annals of Oncology · 被引 5)
• Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial (2026 · Nature Cancer · 被引 4)